Followers | 472 |
Posts | 37018 |
Boards Moderated | 0 |
Alias Born | 01/11/2004 |
Thursday, March 18, 2021 10:44:13 AM
Q: Can you give us more insights into your growth strategy?
A: We are currently in the middle of a Reg A+ raise and have been and will continue to deploy that capital into good revenue producing assets. So essentially, raise capital and do the right thing with it. All of the properties we are buying are considered Real Property, so we get double bang for the buck. Not only do we get revenue for every dime we invest, but we also get a valuable asset that flows across to the Balance Sheet.
Q: What is your long-term vision?
A: Ultimately, I would like to raise and deploy approximately $5 million in short order. That would buy approximately $2.0-$3.0 million in annual revenue which is a good place to be. Along the way, I want to get VBHI qualified as penny stock exempt and listed on the OTCQB or higher.
Q: Can you tell us something about ever flowing pipeline of potential acquisitions?
A: Through my years of doing this, I have built a network of what I believe are the best deal people in the business. We source at multiple levels; from the grassroots level where we are calling mineral owners identified in tax rolls to acquiring portfolios from other companies similar to VBHI. We also get a lot of deals from trust and wealth managers.
Q: What can we expect from Verde Bio Holdings in next 6 months? What are your plans?
A: VBHI will make a big splash over the next 6 months. We are continuing to raise significant capital through our Reg A+ and deploying that as quickly as possible into good, quality assets. As I mentioned, I would like to see an uplist and penny stock exempt over the next six months to give investors better access to trading our shares.
Q: Is Verde communicating with the shareholder public?
A: We have announced in three separate news releases, which you can find at Yahoo Finance or OTCMarkets.com under our stock symbol, VBHI, that we have acquired royalty interests in natural gas rich and oil rich areas.
https://www.superbcrew.com/an-interview-with-scott-cox-chief-executive-officer-of-verde-bio-holdings/
$VBHI
Recent VBHI News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/05/2024 03:38:56 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/05/2024 01:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:11:02 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:48:32 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:17:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:09:12 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/15/2023 01:04:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 01:03:07 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/14/2023 10:08:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:58:57 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 10/17/2023 06:36:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:49:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/10/2023 05:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 08:36:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/19/2023 05:49:23 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/31/2023 09:28:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 04:01:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM